1-20 of 921 Search Results for

firm

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
×Close Modal
Sort by
Image
Published: 01 April 2016
Figure 2 Trends in Average Firm R&D and SG&A Expenditures (in Millions of Dollars), 1999–2009 Source : Authors' analyses of data from firms' 10-K filings with the Securities and Exchange Commission, available in Mergent or Compustat, for firms with at least one NDA approval from the More
Journal Article
Journal of Health Politics, Policy and Law (1 August 2001) 26 (4): 798–803.
Published: 01 August 2001
...Jon R. Gabel Jill Mathews Yegian. Size Matters: The Health Insurance Market for Small Firms. Brookfield, VT: Ashgate, 1999. 171 pp. $64.95 cloth. © 2001 by Duke University Press 2001 Gabel, J., L. Levitt, E. Holve, J. Pickreign, H. Whitmore, S. Hawkins, and N. Miller. 2000 . Job-Based Health...
Journal Article
Journal of Health Politics, Policy and Law (1 August 1996) 21 (4): 697–750.
Published: 01 August 1996
... five forms of community benefit that might be associated with nonprofit forms of managed care. Using data from a national survey of firms providing third-party utilization review services in 1993, we test for ownership-related differences in these five dimensions. The results suggest that ownership...
Image
Published: 01 April 2016
Figure 1 Trends in NDA Approvals for Publicly Traded Firms, 1999–2009 Source : Authors' analyses of data from Drugs@FDA for publicly traded firms. Complete description in “Data” section. Notes : NDAs=new drug applications; NME=new molecular entity Figure 1. Trends in NDA Approvals for More
Journal Article
Journal of Health Politics, Policy and Law (1 October 2014) 39 (5): 989–1012.
Published: 01 October 2014
... of the worker both represent a productivity-enhancing investment in the worker by the firm. The problem is that the employer frequently fails to capture the returns on the investment. A healthier or better-skilled worker can command a higher wage and threaten to leave the firm making the investment...
Journal Article
Journal of Health Politics, Policy and Law (1 April 2016) 41 (2): 157–179.
Published: 01 April 2016
...Figure 2 Trends in Average Firm R&D and SG&A Expenditures (in Millions of Dollars), 1999–2009 Source : Authors' analyses of data from firms' 10-K filings with the Securities and Exchange Commission, available in Mergent or Compustat, for firms with at least one NDA approval from the...
Journal Article
Journal of Health Politics, Policy and Law (1 April 1997) 22 (2): 557–593.
Published: 01 April 1997
... interventions at both the firm and public policy levels. Although currently enthusiastic about market–oriented managed care, large employers have been periodically disappointed by firm–level market experiments during the past two decades. They viewed with skepticism the Republican proposal to apply private...
Journal Article
Journal of Health Politics, Policy and Law (1 February 2004) 29 (1): 11–42.
Published: 01 February 2004
... a very different relationship to firm-level quality, where firms within a chain that is being sued have higher levels of inspection-oriented quality. Our results suggest that legal claims may result from quality problems that go unmeasured during the inspection process. However, more research in...
Journal Article
Journal of Health Politics, Policy and Law (1 February 2008) 33 (1): 93–115.
Published: 01 February 2008
... services, the government's program was a hastily implemented attempt to place primary care, the delivery of which is dominated by private doctors, under firm state control. It was also an attempt to override preexisting arrangements. As such, the government succeeded in its goal of establishing new primary...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2008) 33 (3): 429–453.
Published: 01 June 2008
.../commercial product mix; (2) attracting nonresidents to use the community's retail and public space; and (3) capitalizing on community investment not simply from residents' organizing efforts but, more important in this case, from corporate community involvement by a Greendale business firm whose interests...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2010) 35 (3): 407–422.
Published: 01 June 2010
...Michael Birnbaum Michael Birnbaum interviews Deborah Bachrach about her three-year tenure as director of the nation's largest Medicaid program. Bachrach, who served under Governors Spitzer and Paterson, had previously spent over a decade as a partner in a New York law firm, navigating and shaping...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2006) 31 (3): 511–529.
Published: 01 June 2006
... heterogeneity of local health care markets, it advises courts not to accept the FTC's preemptive standard regarding the significance of hospitals' nonprofit status and keep open the possibility of fashioning new presumptive rules tailored to more complete economic accounts of nonprofit firm behavior. Duke...
Journal Article
Journal of Health Politics, Policy and Law (1 February 1991) 16 (1): 1–18.
Published: 01 February 1991
... health policy. The political feasibility of the new standard is traced to OSHA's abandonment of “technology forcing” in favor of reliance on “off-the-shelf” technologies already in use in major firms. While important as an embodiment of OSHA's new “generic” approach to regulation, the Air Contaminants...
Journal Article
Journal of Health Politics, Policy and Law (1 June 1977) 2 (3): 319–334.
Published: 01 June 1977
... commissioner; the anticipated passage of national health insurance; and the increased competition from commercial insurance carriers, specialty health care data and management firms and state governments. In concluding, the question is raised whether society should invest further in the future of Blue Cross, a...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2011) 36 (3): 513.
Published: 01 June 2011
... employers in the ACA and considers whether these provisions will help such firms offer coverage. © 2011 by Duke University Press 2011 A Critical Look at Substantive Issues Abstract  Media coverage of the Patient Protection and Affordable Care Act (ACA...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2013) 38 (3): 505–544.
Published: 01 June 2013
... to advance theoretical understanding of firms' public affairs strategies. We recommend policy responses to prevent deceptive practices, protect children from adult content, and promote genuine health care education. © 2013 by Duke University Press 2013 References Abraham John . 2009...
Journal Article
Journal of Health Politics, Policy and Law (1 February 1986) 11 (1): 1–18.
Published: 01 February 1986
...James C. Robinson This paper studies the link between occupational health hazards and job security. Consistent with the underlying hypothesis that firms utilizing hazardous technologies tend to employ low-skilled workers who can be discharged easily in case of a downturn in business, the analysis...
Journal Article
Journal of Health Politics, Policy and Law (1 February 2014) 39 (1): 5–34.
Published: 01 February 2014
... historically determined legitimating ideology of US firms. From the era of the “corporate commonwealth,” US business inherited the principles of private welfare provision and of resistance to any expansion of government control. Once complementary, these principles are now mutually exclusive: employer-provided...
Journal Article
Journal of Health Politics, Policy and Law (1 August 1995) 20 (4): 973–1000.
Published: 01 August 1995
..., despite several recent interruptions in vaccine production and supply. Moreover, the increasing producer concentration in the U.S. and global vaccine industries raises the possibility that more and more important vaccines will be produced by a single firm, often in a single production facility. Is a...
Journal Article
Journal of Health Politics, Policy and Law (1 April 1997) 22 (2): 509–532.
Published: 01 April 1997
... firms. I suggest that we cannot understand managed care unless we understand its power as at least substantially due to its reliance on a claim to be better science. In this way, managed care needs to be placed within an analytic historical tradition that is concerned with how accounts of scientific...